196 
needs and initiatives, in consultation with af-
fected National Drug Control Program agencies, 
including— 
‘‘(i) 
improving 
treatment 
through 
neuroscientific advances; 
‘‘(ii) improving the transfer of bio-
medical research to the clinical setting; and 
‘‘(iii) in consultation with the Na-
tional Institute on Drug Abuse and the 
Substance Abuse and Mental Health Serv-
ices Administration, and through inter-
agency agreements or grants, examining ad-
diction and rehabilitation research and the 
application of technology to expanding the 
effectiveness or availability of drug treat-
ment; 
‘‘(C) make a priority ranking of such needs 
identified in subparagraphs (A) and (B) accord-
ing to fiscal and technological feasibility, as part 
of a National Counterdrug Research and Devel-
opment Program; 
‘‘(D) oversee and coordinate counterdrug 
technology initiatives with related activities of 
other Federal civilian and military departments; 
VerDate Aug 31 2005 
23:52 Mar 03, 2006
Jkt 049200
PO 00000
Frm 00196
Fmt 6652
Sfmt 6203
E:\BILLS\H2829.RH
H2829
jcorcoran on PROD1PC62 with BILLS
197 
‘‘(E) provide support to the development 
and implementation of the national drug control 
performance measurement system established 
under subsection (b) of section 706; 
‘‘(F) with the advice and counsel of experts 
from State and local law enforcement agencies, 
oversee and coordinate a technology transfer pro-
gram for the transfer of technology to State and 
local law enforcement agencies; and 
‘‘(G) pursuant to the authority of the Direc-
tor of National Drug Control Policy under sec-
tion 704, submit requests to Congress for the re-
programming or transfer of funds appropriated 
for counterdrug technology research and develop-
ment. 
‘‘(2) 
PRIORITIES
IN
TRANSFERRING
TECH-
NOLOGY.— 
‘‘(A) IN
GENERAL.—The Chief Scientist 
shall give priority, in transferring technology 
under paragraph (1)(F), based on the following 
criteria: 
‘‘(i) the need of potential recipients for 
such technology; 
VerDate Aug 31 2005 
23:52 Mar 03, 2006
Jkt 049200
PO 00000
Frm 00197
Fmt 6652
Sfmt 6203
E:\BILLS\H2829.RH
H2829
jcorcoran on PROD1PC62 with BILLS
198 
‘‘(ii) the effectiveness of the technology 
to enhance current counterdrug activities of 
potential recipients; and 
‘‘(iii) the ability and willingness of po-
tential recipients to evaluate transferred 
technology. 
‘‘(B) INTERDICTION
AND
BORDER
DRUG 
LAW ENFORCEMENT TECHNOLOGIES.—The Chief 
Scientist shall give priority, in transferring tech-
nologies most likely to assist in drug interdiction 
and border drug law enforcement, to State, local, 
and tribal law enforcement agencies in southwest 
border areas and northern border areas with sig-
nificant traffic in illicit drugs. 
‘‘(3) LIMITATION ON AUTHORITY.—The authority 
granted to the Director under this subsection shall not 
extend to the direct management of individual 
projects or other operational activities. 
‘‘(4) REPORT.—On or before July 1 of each year, 
the Director shall submit a report to the appropriate 
congressional committees that addresses the following: 
‘‘(A) The number of requests received during 
the previous 12 months, including the identity of 
each requesting agency and the type of tech-
nology requested. 
VerDate Aug 31 2005 
23:52 Mar 03, 2006
Jkt 049200
PO 00000
Frm 00198
Fmt 6652
Sfmt 6203
E:\BILLS\H2829.RH
H2829
jcorcoran on PROD1PC62 with BILLS
199 
‘‘(B) The number of requests fulfilled during 
the previous 12 months, including the identity of 
each recipient agency and the type of technology 
transferred. 
‘‘(C) A summary of the criteria used in 
making the determination on what requests were 
funded and what requests were not funded, ex-
cept that such summary shall not include spe-
cific information on any individual requests. 
‘‘(D) A general assessment of the future 
needs of the program, based on expected changes 
in threats, expected technologies, and likely need 
from potential recipients. 
‘‘(E) An assessment of the effectiveness of 
the technologies transferred, based in part on the 
evaluations provided by the recipients, with a 
recommendation whether the technology should 
continue to be offered through the program.’’. 
(c) ASSISTANCE FROM SECRETARY OF HOMELAND SE-
CURITY.—Section 708(d) (21 U.S.C. 1707(d)) is amended 
by inserting ‘‘, the Secretary of Homeland Security,’’ after 
‘‘The Secretary of Defense’’. 
SEC. 12. NATIONAL YOUTH ANTIDRUG MEDIA CAMPAIGN. 
(a) IN GENERAL.—Section 709 (21 U.S.C. 1708) is 
amended to read as follows: 
VerDate Aug 31 2005 
23:52 Mar 03, 2006
Jkt 049200
PO 00000
Frm 00199
Fmt 6652
Sfmt 6203
E:\BILLS\H2829.RH
H2829
jcorcoran on PROD1PC62 with BILLS
200 
‘‘SEC. 709. NATIONAL YOUTH ANTIDRUG MEDIA CAMPAIGN. 
‘‘(a) IN GENERAL.—The Director shall conduct a na-
tional youth anti-drug media campaign (referred to in this 
subtitle as the ‘national media campaign’) in accordance 
with this section for the purposes of— 
‘‘(1) preventing drug abuse among young people 
in the United States; 
‘‘(2) increasing awareness of adults of the impact 
of drug abuse on young people; and 
‘‘(3) encouraging parents and other interested 
adults to discuss with young people the dangers of il-
legal drug use. 
‘‘(b) USE OF FUNDS.— 
‘‘(1) IN GENERAL.—Amounts made available to 
carry out this section for the national media cam-
paign may only be used for the following: 
‘‘(A) The purchase of media time and space, 
including the strategic planning for, and ac-
counting of, such purchases. 
‘‘(B) Creative and talent costs, consistent 
with paragraph (2)(A). 
‘‘(C) Advertising production costs. 
‘‘(D) Testing and evaluation of advertising. 
‘‘(E) Evaluation of the effectiveness of the 
national media campaign. 
VerDate Aug 31 2005 
23:52 Mar 03, 2006
Jkt 049200
PO 00000
Frm 00200
Fmt 6652
Sfmt 6203
E:\BILLS\H2829.RH
H2829
jcorcoran on PROD1PC62 with BILLS